Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2023-504071-24-00Phase 2Authorised
Phase 2, randomised, double-blind trial in brain neoplasm comparing Lithionit (lithium) arm with Placebo arm (2 arms). Planned start May 2023; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2023-504071-24-00.